ACC 2014 Report: Transcatheter aortic valve replacement (TAVR) with a self-expanding prosthesis achieves lower mortality than surgery: CoreValve US Pivotal Trial
by Bruce Sylvester – Severe aortic stenosis patients undergoing transcatheter aortic valve replacement (TAVR) with a self-expanding bioprosthesis have achieved a significantly higher rate of survival at one… read more.